CME Group Inc.

CMENASDAQFinancial Services● Active

$250.92

$-6.48(-2.52%)

Market Cap$90.9B

P/E Ratio—

52W High$329.16

52W Low$244.56

Avg Volume2.6M

Open$255.67

Beta0.24

Free Cash Flow Financials Revenue

CME Group Inc. (CME) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CME · free cash flow · updated Jun 8, 2026

Core FCF metrics

CME · FCF · TTM · margin & CAGR

Free cash flow was $4.19B for FY2025 (fiscal year ending 2025-12-31), up 16.6% year-over-year The FCF margin was 64.3%. Five-year CAGR stands at +10.7%.

FY2025 Free Cash Flow$4.19B▲ +16.6% YoY

Trailing 12M (TTM)$4.33Btrailing 4 quarters sum

FCF Margin64.3%$4.19B ÷ revenue

3-Year CAGR+12.2%FY2022 → FY2025

5-Year CAGR+10.7%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CME · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$4.28B(84M)$4.19B▲ +16.6%64.3%

FY2024$3.69B(94M)$3.60B▲ +6.5%58.7%

FY2023$3.45B(76M)$3.38B▲ +13.9%60.5%

FY2022$3.06B(90M)$2.97B▲ +30.4%59.1%

FY2021$2.40B(127M)$2.28B▼ 9.6%48.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CME · P/FCF · FCF yield · FCF per share

CME Group Inc. (CME) trades at a FCF yield of 4.64% and a price-to-free-cash-flow ratio of 20.8x. FCF per share stands at $12.04, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

4.64%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$12.04

TTM FCF ÷ Shares Outstanding

Price / FCF

x20.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CME · cash flow statement · operating / investing / financing

For FY2025, CME Group Inc. generated $4.28B in operating cash flow and spent 84M in capital expenditures, yielding $4.19B in free cash flow.

Operating Activities

+$4.28B

Cash from core business operations

2025-12-31

Investing Activities

+$1.50B

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$56.51B

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($4.28B) − |CapEx| (84M) = FCF ($4.19B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Financial Services)

CME vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CME Group Inc.YOU

CME

$4.19B+16.6%64.3%

Berkshire Hathaway Inc.

BRK-B

$25.04B+115.6%6.7%

25%

Berkshire Hathaway Inc.

Mastercard Incorporated

$16.91B+18.2%51.6%

17%

Financial Services · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CME Group Inc. (CME) reported free cash flow of $4.19B for FY2025 (fiscal year ending 2025-12-31), up 16.6% year-over-year. The FCF margin was 64.3%.

Based on available data, CME Group Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $4.19B in FY2025. The 5-year CAGR stands at +10.7%.

CME Group Inc.'s FCF yield is 4.64% and price-to-FCF ratio is 20.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CME free cash flow · 8 questions

CME Group Inc. free cash flow was $4.19B for FY2025, up 16.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $4.33B.

CME free cash flowCME FCFCME FCF 2025CME free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CME Group Inc. · CME Group Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026